NEXGEL, Inc.

NasdaqCM:NXGL

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

💄 Cosmetics

🩺 Medical Instruments

🧴 Personal Care

💊 Pharmaceuticals

Location

United States

Market Cap

USD 20.59 M

Share Price

USD 2.69

Avg Daily Volume

46,951

Change (1 day)

1.89%

Change (1 year)

-0.74%

Change (YTD)

-39.69%

NEXGEL, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -32.38%

NEXGEL, Inc. EBIT Margin is -32.38% for the Trailing 12 Months (TTM) ending March 31, 2025, a -52.87% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

NEXGEL, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -68.71%, a -50.01% change year over year.
NEXGEL, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -137.44%, a -20.41% change year over year.
NEXGEL, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -172.69%, a -46.36% change year over year.
NEXGEL, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -321.97%, a 46.64% change year over year.